Eric Risser compensation by year
MACROGENICS Summary Compensation Table · all 7 fiscal years held| Component | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2025 |
|---|---|---|---|---|---|---|---|
| Salary | $350,157 | $374,670 | $393,404 | $387,806 | $431,077 | $427,957 | $561,568 |
| Bonus | $0 | $0 | $0 | $0 | $0 | $0 | $150,000 |
| Stock awards | $0 | $0 | $0 | $0 | $0 | $0 | $52,000 |
| Option awards | $438,458 | $705,392 | $1,334,529 | $1,248,242 | $641,133 | $1,328,091 | $1,049,386 |
| Non-equity incentive | $116,385 | $176,800 | $148,549 | $135,177 | $170,284 | $135,327 | $251,900 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $7,950 | $8,100 | $8,250 | $8,400 | $8,550 | $8,700 | $14,000 |
| Total | $912,950 | $1,264,962 | $1,884,732 | $1,779,625 | $1,251,044 | $1,900,075 | $2,078,854 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MACROGENICS INC DEF 14A filed April 8, 2026, accession 0001125345-26-000021, and prior-year filings.
How this page was built: the MACROGENICS INC filed document, accession 0001125345-26-000021. Every figure is read from that document and cited to the page and table it appears in. Filed April 8, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 22,332 | $35,955 | — |
| RSU | 20,000 | $32,200 | — |
| RSU | 16,665 | $26,831 | — |
| Option | 10,625 | — | $10.15 |
| Option | 62,500 | — | $4.82 |
| Option | 50,625 | — | $18.30 |
| Option | 97,500 | — | $2.60 |
| Option | 550,000 | — | $1.66 |
Per the Outstanding Equity Awards at Fiscal Year-End table in MACROGENICS INC's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
MACROGENICS’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Eric Risser · this page | President, Chief Executive Officer and Director | $2,078,854 |
| Ezio Bonvini | Senior Vice President, Research and Chief Scientific Officer | $1,224,038 |
| James Karrels | Senior Vice President and Chief Financial Officer | $1,149,232 |
| Scott Koenig | Former Chief Executive Officer and current Director | $952,961 |
Board service
MACROGENICS board · FY2025How this board is paid
Company policy: MACROGENICS pays directors a $45,000 cash retainer. As stated in MACROGENICS's FY2025 proxy.
The full MACROGENICS compensation record
free company briefThis page is one person within MACROGENICS's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the MACROGENICS proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order MACROGENICS's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MACROGENICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.